# PRIAPUS-PCa Study: Stereotactic Body Radiation Therapy (SBRT) and Androgen Deprivation Therapy (ADT) Impact on Sexual Function on Men With Unfavorable Intermediate Risk Prostate Cancer

> **NCT07460726** · — · NOT_YET_RECRUITING · sponsor: **CancerCare Manitoba** · enrollment: 130 (estimated)

## Conditions studied

- Prostate Cancer (Adenocarcinoma)
- Erectile Abnormalities
- Sexual Dysfunction Male

## Interventions

- **COMBINATION_PRODUCT:** SBRT combined with ADT

## Key facts

- **NCT ID:** NCT07460726
- **Lead sponsor:** CancerCare Manitoba
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-16
- **Primary completion:** 2028-03-16
- **Final completion:** 2029-12-31
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2026-03-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07460726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07460726, "PRIAPUS-PCa Study: Stereotactic Body Radiation Therapy (SBRT) and Androgen Deprivation Therapy (ADT) Impact on Sexual Function on Men With Unfavorable Intermediate Risk Prostate Cancer". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT07460726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*